Biggest Differences
- FDA enforcement recordBrooksville Pharmaceuticals has no FDA enforcement actions on record; ReviveRX has an active FDA warning letter.
- Vial Score gap (12 points)Brooksville Pharmaceuticals scores 50/100 to ReviveRX's 38/100, a 12-point spread driven by the differences below.
- Geographic reachReviveRX is available in 45 states compared to Brooksville Pharmaceuticals's 1, which may decide the question before any other signal if you're outside Brooksville Pharmaceuticals's footprint.
Comparison based on public federal and state records including NPI Registry, FDA enforcement database, and PCAB accreditation directory. Updated weekly. Not a medical endorsement.
What’s next
Make your next move
Track this matchup
Get alerts if either provider’s score moves.
See the top-rated Compounding Pharmacy platforms
View the highest-scoring providers in this category.
Open the leaderboard →Or check any provider
Share this comparison
Other matchups
Related comparisons
This page evaluates compliance signals, not clinical outcomes. Consult a licensed physician before starting any therapy, medication, or treatment. Vial does not provide medical advice.
